The study will longitudinally track clinical, environmental, lifestyle, diet-associated, and fertility outcome metrics from 4,500 women.
Immunexpress granted 510(k) clearance for its novel diagnostic in differentiating sepsis from SIRS in critical patients.
Racial disparities in disease, particularly breast cancer, continue to pose a major challenge in healthcare.
Frost & Sullivan report notes shift to targeted treatments, the falling cost of omics profiling, and healthcare digitization
The collaboration will apply Viatar's novel circulating tumor cell collection technology in combination with Interpace’s PancraGEN™ assay.
The $3 million investment from New Science Ventures will allow the company to speed adoption of it PCDx genomic profiling test.
All payers agreed with two of the five identified factors: Panels do not fit within current coverage frameworks and lack necessary evidence.
Researchers find over 200 genetic markers that could help in the prediction of hair loss.
Partnership focused on targeted therapeutic biomarker validation, optimization, development, and commercialization.
Patients will receive Perthera's Precision Cancer Analysis service, a multi-omics approach to tissue analysis that enables precision therapy